Imported leishmaniasis: A heterogeneous group of diseases

Journal of Travel Medicine

Volumn 16, Issue 6, 2009, Pages 395-401

  Pérez Ayala, Ana ^a   Norman, Francesca ^a   Pérez Molina, José Antonio ^a   Herrero, Juan María ^a   Monge, Begoña ^a   López Vélez, Rogelio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; ITRACONAZOLE; KETOCONAZOLE; MILTEFOSINE; PENTOXIFYLLINE; STEROID;

ADOLESCENT; ADULT; AFRICA; ARTICLE; ASTHMA; CLINICAL ARTICLE; DRUG WITHDRAWAL; FEMALE; GEOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMIGRANT; IMMUNE DEFICIENCY; IMMUNOTHERAPY; LEISHMANIASIS; MALE; MUCOCUTANEOUS LEISHMANIASIS; OUTCOME ASSESSMENT; PATIENT REFERRAL; PHYSICIAN; RETROSPECTIVE STUDY; SKIN LEISHMANIASIS; SPAIN; TRAVEL; TREATMENT RESPONSE; TROPICAL MEDICINE; UNSPECIFIED SIDE EFFECT; VISCERAL LEISHMANIASIS;

ADULT; AFRICA; ANTIFUNGAL AGENTS; ANTIMONY; ANTIPROTOZOAL AGENTS; ASIA; EMIGRATION AND IMMIGRATION; ENDEMIC DISEASES; EUROPE; FEMALE; HUMANS; IMMUNOTHERAPY; LATIN AMERICA; LEISHMANIA; LEISHMANIASIS; MALE; MIDDLE AGED; MIDDLE EAST; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SPAIN; TRAVEL; TREATMENT OUTCOME;

EID: 70449413197     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2009.00341.x     Document Type: Article

References (33)

1. WHO. Control of the leishmaniases. Geneva : World Health Organ Tech Rep Ser, 1990.
2. Reithinger R, Dujardin JC, Louzir H, et al. Cutaneous leishmaniasis. Lancet Infect Dis 2007 7 : 581 596.
3. Schwartz E, Hatz C, Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis 2006 6 : 342 349.
4. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet Infect Dis 2005 366 : 1561 1577.
5. Beltrame A, Arzese A, Camporese A, et al. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B. J Travel Med 2008 15 : 358 360.
6. Delgado O, Silva S, Coraspe V, et al. Cutaneous leishmaniasis imported from Colombia to Northcentral Venezuela: implications for travel advice. Travel Med Infect Dis 2008 6 : 376 379.
7. Singer C, Armstrong D, Jones TC, Spiro RH. Imported mucocutaneous leishmaniasis in New York City. Report of a patient treated with amphotericin B. Am J Med 1975 59 : 444 447.
8. Rosbotham JL, Corbett EL, Grant HR, et al. Imported mucocutaneous leishmaniasis. Clin Exp Dermatol 1996 21 : 288 290.
9. Lawn SD, Whetham J, Chiodini PL, et al. New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. QJM 2004 97 : 781 788.
10. Weitzel T, Muhlberger N, Jelinek T, et al. Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network. Eur J Clin Microbiol Infect Dis 2005 24 : 471 476.
11. Lohuis PJ, Lipovsky MM, Hoepelman AI, et al. Leishmania braziliensis presenting as a granulomatous lesion of the nasal septum mucosa. J Laryngol Otol 1997 111 : 973 975.
12. Ahluwalia S, Lawn SD, Kanagalingam J, et al. Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America. BMJ 2004 329 : 842 844.
13. Scope A, Trau H, Bakon M, et al. Imported mucosal leishmaniasis in a traveler. Clin Infect Dis 2003 37 : e83 87.
14. Costa JW Jr., Milner DA Jr., Maguire JH. Mucocutaneous leishmaniasis in a US citizen. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 96 : 573 577.
15. Blum J, Junghanss T, Hatz C. Erroneous tracks in the diagnosis of cutaneous and mucocutaneous leishmaniasis. Schweiz Rundsch Med Prax 1994 83 : 1025 1029.
16. Di Lella F, Vincenti V, Zennaro D, et al. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa. Int J Oral Maxillofac Surg 2006 35 : 870 872.
17. Malik AN, John L, Bruceson AD, Lockwood DN. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004. Emerg Infect Dis 2006 12 : 1257 1259.
18. Aliaga L, Cobo F, Mediavilla JD, et al. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients. Medicine (Baltimore) 2003 82 : 147 158.
19. Boakye D, Wilson M, Kweku M. A review of leishmaniasis in West Africa. Ghana Med J 2005 39 : 94 97.
20. Dondji B, Dereure J, Poste B, et al. Visceral leishmaniasis in Cameroon. Seroepidemiologic survey in the Kousseri region, north Cameroon. Bull Soc Pathol Exot 2001 94 : 418 420.
21. Schleucher RD, Zanger P, Gaessler M, Knobloch J. Successful diagnosis and treatment 50 years after exposure: is mucocutaneous leishmaniasis still a neglected differential diagnosis? J Travel Med 2008 15 : 466 467.
22. Niamba P, Traore A, Goumbri-Lompo O, et al. Cutaneous leishmania in HIV patient in Ouagadougou: clinical and therapeutic aspects. Ann Dermatol Venereol 2006 133 : 537 542.
23. Blum J, Desjeux P, Schwartz E, et al. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 2004 53 : 158 166.
24. Gangneux JP, Sauzet S, Donnard S, et al. Recurrent American cutaneous leishmaniasis. Emerg Infect Dis 2007 13 : 1436 1438.
25. Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis 2007 5 : 150 158.
26. White JM, Salisbury JR, Jones J, et al. Cutaneous leishmaniasis: three children with Leishmania major successfully treated with itraconazole. Pediatr Dermatol 2006 23 : 78 80.
27. Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 2007 5 : 873 882. (Pubitemid 47578388)
28. Sundar S, Jha TK, Thakur CP, et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002 347 : 1739 1746.
29. Amato VS, Tuon FF, Siqueira AM, et al. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg 2007 77 : 266 274.
30. Machado PR, Lessa H, Lessa M, et al. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Clin Infect Dis 2007 44 : 788 793.
31. Convit J, Ulrich M, Polegre MA, et al. Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report. Mem Inst Oswaldo Cruz 2004 99 : 57 62.
32. Soto J, Rea J, Balderrama M, et al. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. Am J Trop Med Hyg 2008 78 : 210 211.
33. Soto J, Arana BA, Toledo J, et al. Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis 2004 38 : 1266 1272.